Kiora Pharmaceuticals, Inc.
About
2.68USD-0.15 -5.30%
Closed • Updated at 04:46 GMT+00:00Market Cap$11.88M
Volume45.4K
Beta1.21
RSI56.84
Kiora Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
Apr 14 2026
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway
Apr 9 2026
Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
Apr 7 2026
Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors
Apr 2 2026
Kiora Pharmaceuticals Announces Management Team Changes
Recent Videos
KPRX STOCK : RANGE BREAKOUT | KIORA PHARMACEUTICALS STOCK
May 10, 2026
Lytham Spotlight Series | Kiora Pharmaceuticals (Nasdaq: KPRX)
Apr 21, 2026
Eyecelerator @ AAO 2025 | Posterior / Retina Segment Showcase: Kiora Pharmaceuticals Inc
Jan 10, 2026
Eyecelerator @ Park City 2025 | Retina Showcase: Kiora Pharmaceuticals, Inc
Jan 06, 2026
Community Chat
Ask AI
Try asking